Dr. Fishbein studies a range of serious health conditions, particularly those that affect the heart and lungs, such as pulmonary arterial hypertension (PAH), interstitial lung disease (ILD), and heart transplant rejection. His research often involves innovative techniques, like machine learning algorithms, to enhance diagnostic accuracy for heart transplant patients, and new biopsy methods that reduce risks while providing crucial information for lung disease diagnoses. He also investigates the underlying biological mechanisms of these diseases, seeking ways to improve patient outcomes, especially for those with complex comorbidities.
Key findings
In PAH patients, those with a liver score of MELD-Na ≥12 had poorer lung function, walking an average of 353 meters compared to 411 meters for those with lower scores.
Patients who tested positive with the Envisia Genomic Classifier had a shortened average time to disease progression in ILD of 6,221,487 days compared to those who tested negative.
A machine learning algorithm achieved 98% accuracy in diagnosing pAMR-H in heart transplant biopsies, correctly identifying conditions over 99% of the time.
The use of the Impella 2.5 device in high-risk patients led to a significantly lower death rate of 11%, compared to 46% in those using an IABP device during heart procedures.
The new transbronchial cryobiopsy procedure showed a 4.9% chance of complications, with no deaths within 30 days, indicating a safer diagnostic option for lung disease.
Frequently asked questions
Does Dr. Fishbein study pulmonary diseases?
Yes, he studies pulmonary diseases like pulmonary arterial hypertension and interstitial lung disease, focusing on their impact on patient health.
What innovative techniques has Dr. Fishbein researched?
He has researched machine learning algorithms to improve diagnostic accuracy in heart transplant patients and advanced biopsy techniques for lung diseases.
How does Dr. Fishbein's work help patients with heart issues?
His research identifies better diagnostic methods and treatments for patients with heart conditions, particularly those who have had heart transplants.
What are the implications of Dr. Fishbein's research on COVID-19?
His work on an enzyme therapeutic for COVID-19 shows promise for reducing inflammation and viral replication, which could lead to effective treatments.
Are the findings from Dr. Fishbein's studies relevant to patients with inherited heart conditions?
Yes, they are relevant as they provide insights into better management and diagnostic practices for young patients who may face sudden cardiac death due to inherited conditions.
Publications in plain English
Progression of interstitial lung disease after the Envisia Genomic Classifier.
2025
ERJ open research
Chung A, Oh A, Durant C, Watson R, Channick J +7 more
Plain English This study looked at how the Envisia Genomic Classifier (EGC) test can predict the progression of interstitial lung disease (ILD) in patients. The findings showed that patients who tested positive with the EGC had a significantly shorter time without disease progression—an average of 6,221,487 days—compared to those who tested negative. This matters because identifying patients at higher risk for aggressive disease early on can lead to better management and treatment decisions, without needing more invasive procedures.
Who this helps: Patients with interstitial lung disease and their doctors benefit from this information.
The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension.
2025
bioRxiv : the preprint server for biology
Singh N, Lawson J, Ragavendran A, Banerjee S, Hon A +16 more
Plain English This study looked at how the liver might play a role in pulmonary arterial hypertension (PAH), a condition that affects blood vessels in the lungs. Researchers examined 25 PAH patients and found that those with a specific liver score (MELD-Na ≥12) had worse lung function, measured by a lower ability to walk for six minutes, and higher pulmonary pressure. Notably, patients with this liver score walked an average of 353 meters compared to 411 meters for those with lower scores, indicating a significant decline in physical ability.
Who this helps: This research is beneficial for patients with PAH, especially those with liver problems, as it highlights the connection between liver function and lung health.
HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.
2024
Free neuropathology
Magaki S, Zhang T, Han K, Hilda M, Yong WH +13 more
Plain English This study looked at how HIV and COVID-19 affect the brain. Researchers found that while HIV is known to invade the brain in early infection and cause specific neurological problems, the effects of COVID-19 on the brain are less clear and more generalized. Understanding these differences is important, as both conditions can lead to long-term cognitive issues that we still know little about.
Who this helps: This benefits patients living with HIV and COVID-19, as well as doctors treating them.
A machine learning algorithm improves the diagnostic accuracy of the histologic component of antibody mediated rejection (AMR-H) in cardiac transplant endomyocardial biopsies.
2024
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Glass M, Ji Z, Davis R, Pavlisko EN, DiBernardo L +17 more
Plain English This study looked at how well a machine learning program can identify a specific type of rejection in heart transplant patients called antibody-mediated rejection (pAMR-H) using tissue samples from heart biopsies. The machine learning algorithm correctly identified pAMR-H with an impressive accuracy of 98%, clearly distinguishing it from normal heart tissue (99.2%), healing injuries (99.5%), and acute cellular rejection (99.5%). This is important because accurate diagnosis of pAMR-H can lead to better treatment decisions and improved outcomes for heart transplant patients.
Who this helps: This benefits heart transplant patients and their doctors by providing more reliable diagnostic tools.
Sudden cardiac death in the young: A consensus statement on recommended practices for cardiac examination by pathologists from the Society for Cardiovascular Pathology.
2023
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Kelly KL, Lin PT, Basso C, Bois M, Buja LM +25 more
Plain English This study focuses on sudden cardiac death (SCD) in young people, which affects about 15-20% of all deaths and is often caused by inherited heart conditions. The researchers emphasized the need for better guidelines for pathologists to investigate these cases properly, as many medical examiner offices struggle with limited resources. By following these new recommendations, important family health information can be uncovered, potentially saving lives among relatives.
Who this helps: This helps families with inherited heart conditions and medical professionals involved in their care.
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.
2023
Hypertension (Dallas, Tex. : 1979)
Razee A, Banerjee S, Hong J, Magaki S, Fishbein G +2 more
Plain English Researchers studied the role of inflammation in the thoracic spinal cord and its effect on pulmonary hypertension (PH), which can lead to heart failure and arrhythmias. They found that treating rats with an anti-inflammatory drug called minocycline significantly reduced heart strain and symptoms of PH, improving their condition. Specifically, the treatment decreased activation of harmful cells in the spinal cord, which corresponded with reduced sympathetic nervous system activity and overall better heart function.
Who this helps: This helps patients with pulmonary hypertension and related heart issues.
Unsupervised mRNA-seq classification of heart transplant endomyocardial biopsies.
2023
Clinical transplantation
Romero E, Tabak E, Fishbein G, Litovsky S, Tallaj J +7 more
Plain English This study focused on improving how doctors diagnose heart transplant rejection using endomyocardial biopsies (EMBs). Researchers analyzed 64 EMBs from 47 patients using a new method based on gene expression instead of traditional histology. They found that their algorithm could classify the biopsies into three distinct categories linked to heart and immune function, showing a strong correlation with clinical observations. This matters because a more objective evaluation method can lead to better diagnosis and treatment of heart transplant rejections.
Who this helps: This helps heart transplant patients and their doctors.
Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts.
2023
JCI insight
Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N +7 more
Plain English This study focused on a molecule called microRNA-129-5p and its role in preventing heart tissue changes that can worsen heart failure. Researchers found that lower levels of microRNA-129-5p led to increased levels of two proteins, Asporin and Sox9, which promote harmful changes in heart cells. By introducing microRNA-129-5p back into heart cells, they were able to reduce issues related to heart fibrosis and calcification, improving heart function in their experiments.
Who this helps: This benefits heart failure patients by potentially opening new avenues for treatment.
Linear epicardial cryoablation effects in a porcine model: Lesion characteristics and vascular risk.
2023
Journal of cardiovascular electrophysiology
Hayase J, Fishbein G, Rerkpichaisuth V, Chung WH, Ajijola O +2 more
Plain English This study looked at how well a specific freezing technique called cryoablation works on heart tissue in pigs, particularly focusing on its effects on lesions created in the heart muscle and potential injury to nearby blood vessels. Researchers found that when the freezing lasted for three minutes, the lesions reached about 1.0 cm deep, but longer freezing didn't make them any deeper, and no major damage to the large coronary artery was observed. However, there were signs of injury to smaller blood vessels nearby, which is important because it may affect the heart's blood supply.
Who this helps: This research benefits doctors and cardiac surgeons working on new treatments for heart rhythm disorders.
Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.
2023
Cancer research
Yanagawa J, Tran LM, Salehi-Rad R, Lim RJ, Dumitras C +19 more
Plain English This study looked at early lung cancer, specifically lung adenocarcinoma, by examining tissue samples from patients with pulmonary nodules. Researchers found that in the early stages, there is a significant drop in immune cell activity, with a 35% decrease in certain protective immune cells, leading to weakened immune defense against the tumor. Understanding these changes helps in developing better ways to diagnose and treat lung cancer early.
Who this helps: This benefits patients at risk for lung cancer and their doctors by providing insights for earlier intervention.
Effects of shell-integrated Sudan Black dye on the acoustic activity and ultrasound imaging properties of lipid-shelled nanoscale ultrasound contrast agents.
2022
Journal of biomedical optics
Wegierak D, Fishbein G, Abenojar E, De Leon A, Zhu J +4 more
Plain English This study looked at how adding a specific dye, Sudan Black B, to tiny bubbles used in ultrasound imaging could improve their performance in both ultrasound and photoacoustic imaging. The researchers found that while the dye improved the imaging quality significantly—showing an increase in imaging power by up to 10 decibels—there was also a reduction in the number of bubbles available for imaging when more dye was added, with a notable 40% decrease at certain concentrations. These findings are important because they suggest a way to enhance imaging techniques that doctors use to better visualize and diagnose conditions in patients.
Who this helps: This helps doctors and patients by improving the quality of diagnostic imaging.
The safety profile of a protocolized transbronchial cryobiopsy program utilizing a 2.4 mm cryoprobe for interstitial lung disease.
2022
Respiratory medicine
Oh S, Ronaghi R, He T, Oberg C, Channick C +9 more
Plain English This study looked at the safety and effectiveness of a new lung biopsy procedure called transbronchial cryobiopsy, specifically using a 2.4 mm tool on 201 patients suspected of having interstitial lung disease. The researchers found that while there was a 4.9% chance of complications like a collapsed lung and a 0.5% chance of severe bleeding, there were no deaths within 30 days of the procedure. This matters because it shows that this method can provide valuable diagnostic information with relatively low risks compared to traditional surgical biopsies.
Who this helps: This helps patients with suspected interstitial lung disease who need a lung biopsy.
Left Ventricular Support for Unprotected Left Main Coronary Artery Interventions (The Dayton Heart and Vascular Impella Registry).
2022
Heart views : the official journal of the Gulf Heart Association
Jabbar AA, Jbara Y, Ebrahimi AJ, Mufti O, Ali O +3 more
Plain English This study looked at patients with serious blockages in a major heart artery and explored the effects of using heart support devices during their treatment. Among 89 patients undergoing a specific procedure, those who used the Impella 2.5 device had a much lower death rate (11%) compared to those who used the IABP device (46%). This matters because it suggests that in high-risk patients, using Impella can lead to better outcomes after heart surgery.
Who this helps: Patients with serious heart conditions and their doctors.
Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
2021
Circulation. Heart failure
Park JF, Clark VR, Banerjee S, Hong J, Razee A +4 more
Plain English This study examined how the right ventricle of the heart changes when facing pulmonary hypertension (PAH) by comparing two types of rat models. Researchers found that both models showed similar changes in gene activity linked to heart failure, including a process called epithelial-to-mesenchymal transition. They also found significant signs of heart tissue damage in humans with PAH-related heart failure, indicating that these changes are relevant to patients as well.
Who this helps: This helps patients with pulmonary hypertension and their doctors by identifying potential new treatment strategies.
Involvement of Low-Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension.
2020
Journal of the American Heart Association
Umar S, Ruffenach G, Moazeni S, Vaillancourt M, Hong J +11 more
Plain English This study looked at how a protein called low-density lipoprotein receptor (LDL-R) affects pulmonary hypertension (PH), a condition where the blood pressure in the lungs becomes too high. Researchers found that patients with PH had lower levels of LDL-R in their lungs and higher levels of oxidized lipids, which are harmful fats. In experiments with mice, those missing LDL-R developed serious symptoms of PH, including heart and lung damage, but a specific treatment helped prevent these issues.
Who this helps: This research benefits patients with pulmonary hypertension and the doctors treating them.
Plain English Researchers studied a treatment for COVID-19 using an enzyme called catalase, which helps break down harmful substances in the body. They found that catalase can reduce inflammation and virus replication without causing side effects in human cells and in monkeys. This approach could lead to an affordable and effective therapy for COVID-19, filling a gap where there are currently no specific antiviral drugs available.
Who this helps: This helps patients with COVID-19.
Pulmonary and Bronchiolar Involvement in Sjogren's Syndrome.
2019
Seminars in respiratory and critical care medicine
Chung A, Wilgus ML, Fishbein G, Lynch JP
Plain English This study looked at how Sjogren's syndrome, an autoimmune disease that mainly causes dry eyes and dry mouth, can also affect the lungs and airways. Researchers found that while lung issues are not the main focus of Sjogren's syndrome, they can occur in 30-40% of patients and may include serious problems like lung infections and fibrosis. Understanding these lung complications is important for improving diagnosis and treatment for those with Sjogren's syndrome.
Who this helps: This helps patients with Sjogren's syndrome, particularly those experiencing lung-related symptoms.
Contrast enhanced ultrasound imaging by nature-inspired ultrastable echogenic nanobubbles.
2019
Nanoscale
de Leon A, Perera R, Hernandez C, Cooley M, Jung O +8 more
Plain English Researchers developed a new type of ultrasound contrast agent called ultrastable nanobubbles, designed to improve the quality and stability of ultrasound imaging inside the body. They found that these nanobubbles can stay effective longer during ultrasound scans, showing minimal signal loss even after prolonged use in tests, which is an improvement over previous contrast agents. This matters because better imaging can lead to more accurate diagnoses and treatments, especially for conditions affecting the kidney, liver, and tumors.
Who this helps: This helps patients undergoing ultrasound imaging and doctors who need accurate diagnostic tools.
Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis.
2019
EMBO molecular medicine
Ruffenach G, Umar S, Vaillancourt M, Hong J, Cao N +8 more
Plain English This study looked at a type of high blood pressure in the lungs caused by lung scarring, known as pulmonary fibrosis. Researchers found that patients with this condition had thicker blood vessel walls in their lungs and higher levels of a protein called Slug, which is linked to lung damage and muscle cell growth. By using a rat model, they demonstrated that blocking Slug could lessen the severity of pulmonary hypertension.
Who this helps: This research benefits patients with pulmonary fibrosis and associated pulmonary hypertension, as it may lead to new treatment options.
Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension.
2019
ACR open rheumatology
Seki A, Anklesaria Z, Saggar R, Dodson MW, Schwab K +24 more
Plain English This study examined lung samples from patients with a condition called systemic sclerosis-related pulmonary fibrosis to see if certain features of the lung's blood vessels could identify those with high blood pressure in the lungs (pulmonary hypertension). The researchers found that capillary proliferation, or an increase in tiny blood vessels, was strongly linked to pulmonary hypertension; specifically, having two or more layers of these capillaries or having 10% or more of the lungs affected helped predict the condition accurately 91% of the time. This matters because identifying pulmonary hypertension early can lead to better treatment options for patients.
Who this helps: This helps patients suffering from systemic sclerosis and their doctors in diagnosing and managing their condition.
Roche ET, Horvath MA, Wamala I, Alazmani A, Song SE +10 more
Plain English Researchers developed a soft robotic sleeve that fits around the heart and helps it pump better by squeezing and twisting like heart muscles do. In tests on pigs with heart failure, the sleeve successfully supported heart function without touching the blood, avoiding the need for blood thinners and reducing risks like clots and infections. This new device could provide personalized support for heart failure patients until they can receive a transplant.
Who this helps: Heart failure patients who need temporary support until a transplant.
A 34-Year-Old Woman With Recurrent Right-Sided Chest Pain and Dyspnea.
2015
Chest
Albores J, Fishbein G, Bando J
Plain English The study focused on a 34-year-old woman who experienced repeated episodes of sharp chest pain and shortness of breath on the right side. Each time she had a small collection of air in her lung (called a pneumothorax), which happened during rigorous exercise and around the start of her menstrual period. This matters because it highlights a possible connection between her physical activity and her symptoms, helping to better understand similar cases in the future.
Who this helps: This helps patients experiencing unexplained chest pain and doctors diagnosing similar respiratory issues.
Measuring complete diagnostic evaluation in colorectal cancer screening.
2001
Cancer detection and prevention
Myers RE, Fishbein G, Hyslop T, Hauck WW, Kutch M +2 more
Plain English This study focused on how well different methods can track the use of complete diagnostic evaluations (CDE) in colorectal cancer screening for patients with abnormal stool test results. The researchers found that the combination of internal chart audits and administrative data reviews (called ICA plus ADR) was the most reliable method, achieving a sensitivity of 90.1% for recommendations and 96.5% for performance. These findings are important because accurate tracking of CDE can ensure patients get timely and appropriate follow-up care, which is crucial for early detection and treatment of colorectal cancer.
Who this helps: Patients who receive abnormal colorectal cancer screening results.
Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation.
1994
International journal of radiation oncology, biology, physics
Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G
Plain English This study looked at how combining chemotherapy with high-dose radiation before surgery could help patients with advanced rectal cancer. Out of 31 patients treated, 74% showed improvement in tumor condition, meaning their cancers became easier to remove surgically. The treatment was generally safe, with only minor side effects, and 68% of patients are expected to survive for at least three years after treatment.
Who this helps: This benefits patients with advanced rectal cancer by improving their chances for successful surgery and better survival rates.
Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia.
1991
The American journal of gastroenterology
Rosen AA, Iseri O, Fishbein G, Knodell RG
Plain English The study examined a case of a young woman who developed liver problems, specifically swelling of the liver and fluid buildup in the abdomen, after receiving chemotherapy for leukemia. Instead of a known liver condition, the tests revealed a rare condition called nodular regenerative hyperplasia, which seems to be linked to the liver damage caused by the chemotherapy drugs. Recognizing this condition is important as it helps doctors better understand and manage liver issues in leukemia patients.
Who this helps: This helps patients with leukemia and their healthcare providers.
Plain English This study discusses a rare case of a diabetic patient who developed a serious muscle infection called pyomyositis, caused by group B streptococcus. The infection was initially mistaken for other conditions due to its unusual symptoms and the fact that standard blood tests often did not show the bacteria. Quick treatment with antibiotics and imaging techniques to locate the infection were crucial for recovery.
Who this helps: This helps doctors by highlighting the importance of recognizing this rare infection, especially in diabetic patients.